Proofreading-deficient coronaviruses adapt over long-term passage for increased fidelity and fitness without reversion of exoribonuclease-inactivating mutations
Kevin W. Graepel(National Institutes of Health), Mark R. Denison(Bipar), Nicole R. Sexton(Blood Systems Research Institute), James Brett Case(Washington University in St. Louis), Xiaotao Lu(Vanderbilt University Medical Center), Everett Clinton Smith(Sewanee: The University of the South)
Cited by 6
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
|Science Translational Medicine|2020|1.2k